Related Experiment Video
Updated: May 1, 2026

06:15
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
1.7K
Polymorphism in THBS1 gene is associated with post-refractive surgery chronic ocular surface inflammation
Laura Contreras-Ruiz1, Denise S Ryan2, Rose K Sia2
1Department of Ophthalmology, Boston University School of Medicine, Boston, Massachusetts.
Ophthalmology
|April 1, 2014
Summary
Single nucleotide polymorphisms (SNPs) in the thrombospondin 1 (THBS1) gene are associated with chronic ocular surface inflammation after refractive surgery. Lower THBS1 gene expression increases susceptibility to this condition.
Area of Science:
- Ophthalmology
- Genetics
- Immunology
Background:
- Chronic ocular surface inflammation, such as keratoconjunctivitis, can occur after refractive surgery.
- The thrombospondin 1 (THBS1) gene plays a role in tissue remodeling and inflammation.
- Understanding the genetic factors influencing post-refractive surgery inflammation is crucial for patient outcomes.
Purpose of the Study:
- To investigate the association between single nucleotide polymorphisms (SNPs) in the THBS1 gene and the development of chronic keratoconjunctivitis following refractive surgery.
- To explore the relationship between specific THBS1 gene variations, THBS1 protein expression, and inflammatory markers on the ocular surface.
Main Methods:
- A retrospective cohort study was conducted involving 143 active duty U.S. Army soldiers who underwent refractive surgery.
- DNA was extracted from pre-operative conjunctival impression cytology samples for genotyping of five THBS1 SNPs.
- RNA was extracted from post-operative samples for gene expression analysis (real-time PCR) and participants were monitored for 1 year for keratoconjunctivitis development.
Main Results:
- Carriers of minor alleles for three THBS1 SNPs (rs1478604, rs2228262, rs2292305) showed increased susceptibility to chronic keratoconjunctivitis.
- Specifically, carriers of the rs1478604 minor allele had a significantly higher odds ratio for developing the condition.
- These carriers also exhibited reduced thrombospondin 1 (TSP1) levels and increased interleukin-1β (IL-1β) expression in ocular surface epithelial cells.
Conclusions:
- Genetic variations in the THBS1 gene, leading to decreased TSP1 expression, significantly elevate the risk of chronic ocular surface inflammation post-refractive surgery.
- The findings suggest a genetic predisposition to post-refractive surgery inflammation linked to THBS1 gene polymorphisms.
- Further research with larger sample sizes is recommended to validate these findings and explore therapeutic implications.
Related Concept Videos
Microbiome of the Eye
67
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
67
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81

